Dreavent is a Boston-based biotech venture capital firm with a structured model to connect scientific ecosystems to Boston's biotech infrastructure, engineering assets against confirmed pharmaceutical interest. Our Bio Asset Engineering Platform combines a specialized Linking Team embedded in both the local ecosystem and Boston, a Boston Development Platform where assets are developed to global pharmaceutical standards, and the Dreavent Engine, a proprietary AI-powered investment intelligence system. Spain is the first implementation. The model is designed to scale globally, with Boston as the permanent hub. Dreavent. Connecting Ecosystems.
| Website | http://www.dreavent.com |
| Employees | 10 (3 on RocketReach) |
| Founded | 2020 |
| Address | 1 Broadway, Cambridge, Massachusetts 02142, US |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Biotech Investments, Biotech Venture Capital, Biotechnology Funding, Pharmaceutical Venture Capital, Healthcare Venture Capital, Biotech Startups, Biotech Portfolio, Life Sciences Investing, Early Stage Biotech, Private Equity Biotech, Drug Discovery Investment, Pharmaceutical Investment, Seed Funding Biotech, Medical Technology Investment, Clinical Stage Investment |
Looking for a particular Dreavent employee's phone or email?
Dreavent Questions
Gorka Fius is the CEO and Founder of Dreavent.
3 people are employed at Dreavent.
Dreavent is based in Cambridge, Massachusetts.
Top Dreavent Employees
-
Gorka Fius
CEO and Founder at Dreavent
Boston, MA, US41 -
Brian Gallagher
Venture Partner at Dreavent
Boston, MA, US5+5+ -
Charles Kunsch
Venture Partner at Dreavent
Boston, MA, US25+
Related Companies
